Sernova Corp. (OTCMKTS:SEOVF – Get Free Report) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 149,000 shares, a decline of 33.2% from the November 30th total of 222,900 shares. Based on an average trading volume of 68,200 shares, the short-interest ratio is presently 2.2 days.
Sernova Price Performance
Sernova stock traded down $0.02 during mid-day trading on Monday, reaching $0.15. 30,168 shares of the stock traded hands, compared to its average volume of 28,446. Sernova has a 12-month low of $0.14 and a 12-month high of $0.55. The business’s 50-day moving average is $0.17 and its 200-day moving average is $0.19. The stock has a market capitalization of $48.80 million, a PE ratio of -1.88 and a beta of 1.14.
Sernova (OTCMKTS:SEOVF – Get Free Report) last issued its quarterly earnings results on Monday, December 23rd. The company reported ($0.01) EPS for the quarter.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Further Reading
- Five stocks we like better than Sernova
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- Most active stocks: Dollar volume vs share volume
- Micron: Why Now Is the Time to Be Brave
- Trading Halts Explained
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.